PAVmed (PAVM) Return on Capital Employed Growth (1y) (2017 - 2026)
PAVmed (PAVM) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 216.00 |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 | 1,069.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,069.00 |
| Dec 31, 2025 | -74,146.00 |
| Jun 30, 2025 | -47,275.00 |
| Mar 31, 2025 | -43,486.00 |
| Dec 31, 2024 | 23,482.00 |
| Jun 30, 2024 | 137,143.00 |
| Mar 31, 2024 | 132,567.00 |
| Dec 31, 2023 | 82,786.00 |
| Sep 30, 2023 | 139,988.00 |
| Jun 30, 2023 | -80,365.00 |
| Mar 31, 2023 | -91,406.00 |
| Dec 31, 2022 | -31,888.00 |
| Dec 31, 2019 | -28,549.00 |
| Dec 31, 2018 | -694,731.00 |
| Sep 30, 2018 | -33,855.00 |
| Dec 31, 2017 | 983,625.00 |